NMTR - 9 Meters Biopharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

9 Meters Biopharma's activity chart (see below) currently has 2 price targets and 3 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 15.33 days.

Most recent stock forecast was given by SAMANTHA SEMENKOW from CITI on 18-May-2023.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 13-Feb-2023

$0.75

$0.73 (3650.00%)

3 years 4 months 11 days ago
(18-May-2023)

1/2 (50%)

$0.28 (59.57%)

Show more analysts

What is NMTR (9 Meters Biopharma) average time for price targets to be met?

On average it took 15 days for the stock forecasts to be reached, with an average price target met ratio of 33.33%.

Which analyst most recently updated their price target on NMTR (9 Meters Biopharma)?

Samantha Semenkow

Which analyst has the current lower performing score on NMTR (9 Meters Biopharma) with a proven track record?

SAMANTHA SEMENKOW

Which analyst has the most public recommendations on NMTR (9 Meters Biopharma)?

Samantha Semenkow works at CITI and has 5 price targets and 2 ratings on NMTR

Which analyst is the currently most bullish on NMTR (9 Meters Biopharma)?

Samantha Semenkow with the highest potential upside of $0.73

Which analyst is the currently most reserved on NMTR (9 Meters Biopharma)?

Srikripa Devarakonda with the lowest potential downside of -$0